Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2022
Gene Symbol: ENG
ENG
0.010 AlteredExpression phenotype LHGDN For the first time, we show a strong association between endoglin and EGR-1, increased collagen and SMCs expression, decreased levels of intraplaque thrombosis, and a stable plaque phenotype. 19074480 2009
Entrez Id: 2266
Gene Symbol: FGG
FGG
0.010 Biomarker phenotype LHGDN Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence. 18983496 2009
Entrez Id: 1958
Gene Symbol: EGR1
EGR1
0.010 AlteredExpression phenotype LHGDN For the first time, we show a strong association between endoglin and EGR-1, increased collagen and SMCs expression, decreased levels of intraplaque thrombosis, and a stable plaque phenotype. 19074480 2009
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.010 Biomarker phenotype LHGDN Leptin induces the expression of functional tissue factor in human neutrophils and peripheral blood mononuclear cells through JAK2-dependent mechanisms and TNFalpha involvement. 18308368 2008
Entrez Id: 2244
Gene Symbol: FGB
FGB
0.010 Biomarker phenotype LHGDN Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. 18818200 2008
Entrez Id: 124583
Gene Symbol: CANT1
CANT1
0.010 Biomarker phenotype LHGDN Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo. 18222531 2008
Entrez Id: 721
Gene Symbol: C4B
C4B
0.010 Biomarker phenotype LHGDN Platelet C4d is associated with acute ischemic stroke and stroke severity. 18927458 2008
Entrez Id: 3674
Gene Symbol: ITGA2B
ITGA2B
0.010 Biomarker phenotype LHGDN Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. 18573917 2008
Entrez Id: 10335
Gene Symbol: MRVI1
MRVI1
0.010 Biomarker phenotype LHGDN These findings reveal that interaction between IRAG and InsP3RI has a central role in NO/cGMP-dependent inhibition of platelet aggregation and in vivo thrombosis. 16990611 2007
Entrez Id: 2160
Gene Symbol: F11
F11
0.010 Biomarker phenotype LHGDN Factor XI in haemostasis and thrombosis: past, present and future. 17597996 2007
Entrez Id: 8398
Gene Symbol: PLA2G6
PLA2G6
0.010 Biomarker phenotype LHGDN The increase in iPLA(2) activity and the subsequent accumulation of membrane phospholipid-derived metabolites in HCAEC exposed to hypoxia or thrombin stimulation alone, and particularly in combination, have important implications in inflammation and arrhythmogenesis in atherosclerosis/thrombosis and subsequent myocardial ischemia. 16943248 2007
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 Biomarker phenotype LHGDN Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. 17706955 2007
Entrez Id: 2162
Gene Symbol: F13A1
F13A1
0.010 GeneticVariation phenotype LHGDN Mutations in clotting factors and inflammatory bowel disease. 17156138 2007
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.010 Biomarker phenotype LHGDN Chronic intermittent hypoxia modulates eosinophil- and neutrophil-platelet aggregation and inflammatory cytokine secretion caused by strenuous exercise in men. 17463301 2007
Entrez Id: 3386
Gene Symbol: ICAM4
ICAM4
0.010 Biomarker phenotype LHGDN LW protein: a promiscuous integrin receptor activated by adrenergic signaling. 16564726 2006
Entrez Id: 1634
Gene Symbol: DCN
DCN
0.010 Biomarker phenotype LHGDN Collectively, these data demonstrate that decorin can regulate fibrin organization and reveal a novel mechanism by which extracellular matrix components can participate in hemostasis, thrombosis, and wound repair. 17046817 2006
Entrez Id: 10365
Gene Symbol: KLF2
KLF2
0.010 AlteredExpression phenotype LHGDN Overexpression and silencing of KLF2 in the context of flow, combined with findings from genome-wide analyses of gene expression, demonstrate that the induction of KLF2 results in the orchestrated regulation of endothelial transcriptional programs controlling inflammation, thrombosis/hemostasis, vascular tone, and blood vessel development. 16341264 2006
Entrez Id: 57126
Gene Symbol: CD177
CD177
0.010 AlteredExpression phenotype LHGDN In this cohort, PRV-1 overexpression was associated with a significantly increased risk of thrombosis, whereas decreased c-Mpl expression was not. 15951300 2005
Entrez Id: 6573
Gene Symbol: SLC19A1
SLC19A1
0.010 GeneticVariation phenotype LHGDN G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. 15964598 2005
Entrez Id: 1604
Gene Symbol: CD55
CD55
0.010 Biomarker phenotype LHGDN Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model. 15808686 2005
Entrez Id: 8740
Gene Symbol: TNFSF14
TNFSF14
0.010 Biomarker phenotype LHGDN Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis. 16186421 2005
Entrez Id: 81027
Gene Symbol: TUBB1
TUBB1
0.010 GeneticVariation phenotype LHGDN The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. 15956286 2005
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.010 Biomarker phenotype LHGDN These preliminary studies demonstrate that platelets are a major source of leptin receptor in the circulation, and suggest that leptin-responsive individuals may have a higher risk for obesity-associated thrombosis than non-responsive individuals. 15869602 2005
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
0.010 AlteredExpression phenotype LHGDN This "annexin A5 resistance" identifies a novel mechanism for thrombosis in the aPL syndrome. 15242878 2004
Entrez Id: 708
Gene Symbol: C1QBP
C1QBP
0.010 AlteredExpression phenotype LHGDN The ability of gC1qR to bind proteins involved in complement, coagulation, and kinin systems, as well as viral and bacterial pathogens including S. aureus protein A, supports the hypothesis that gC1qR expressed on activated platelets may contribute directly to thrombosis, inflammation, and endovascular infections. 12574814 2003